Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Dier Mardi Create: Alert

All | News | Filings
Date FiledTypeDescription
05/11/2023 4 Dier Mardi (CFO and CBO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 5,556 shares @ $18, valued at $100k
Bought 875 shares @ $18, valued at $15.8k
Bought 875 shares @ $18, valued at $15.8k
Disposed of 673,621 options to buy @ $5.8766, valued at $4M
Acquired 673,621 options to buy @ $5.8766, valued at $4M
Disposed of 85,226 options to buy @ $18, valued at $1.5M
Acquired 85,226 options to buy @ $18, valued at $1.5M
05/04/2023 4 Dier Mardi (CFO and CBO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Granted 85,226 options to buy @ $18, valued at $1.5M
10/17/2022 4 Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 1,629 shares @ $40.16, valued at $65.4k
10/14/2022 4 Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 3,484 shares @ $38.22, valued at $133.2k
09/19/2022 4 Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 20,000 shares @ $0
06/22/2022 4 Dier Mardi (Director) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 34,300 options to buy @ $4.74, valued at $162.6k
06/17/2022 4 Dier Mardi (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Granted 53,700 options to buy @ $3.75, valued at $201.4k
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/14/2021 4 Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 3,477 shares @ $82.79, valued at $287.9k
Sold 3,261 shares @ $81.16, valued at $264.7k
06/22/2021 4 Dier Mardi (Director) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 23,344 options to buy @ $31.02, valued at $724.1k
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Dier Mardi (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $5.21, valued at $52.1k
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2020 4 Dier Mardi (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $2.7, valued at $27k
04/27/2020 4 Dier Mardi (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Granted 33,250 options to buy @ $16, valued at $532k
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2020 4 Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 16,250 shares @ $0
Paid exercise price by delivering 3,435 shares @ $12.89, valued at $44.3k
Granted 65,000 options to buy @ $12.79, valued at $831.4k
01/14/2020 4 Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 2,125 shares @ $0
Paid exercise price by delivering 1,277 shares @ $13.8, valued at $17.6k
06/06/2019 4 Dier Mardi (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 10,000 options to buy @ $4.8, valued at $48k
05/21/2019 4 Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 5,859 shares @ $0
Paid exercise price by delivering 3,022 shares @ $28.69, valued at $86.7k
Exercised 5,859 rights @ $0
04/08/2019 4 Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Sold 40,486 shares @ $37.3913, valued at $1.5M
03/05/2019 4 Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 9,667 shares @ $33.41, valued at $323k
02/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/15/2019 4 Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 2,125 shares @ $0
Paid exercise price by delivering 868 shares @ $24.25, valued at $21k
09/05/2018 4 Dier Mardi (Interim Co-President & CFO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Exercised 17,500 shares @ $0
Paid exercise price by delivering 8,884 shares @ $29.1764, valued at $259.2k
08/28/2018 4 Dier Mardi (Interim Co-President & CFO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Exercised 17,500 shares @ $0
Paid exercise price by delivering 8,794 shares @ $26.05, valued at $229.1k
06/07/2018 4 Dier Mardi (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 10,000 options to buy @ $27.98, valued at $279.8k
05/24/2018 4 Dier Mardi (Executive VP and CFO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 5,859 shares @ $0
Paid exercise price by delivering 2,514 shares @ $40.82, valued at $102.6k
03/12/2018 4 Dier Mardi (Executive VP and CFO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Disposed/sold 10,465 shares @ $38.6875, valued at $404.9k
Disposed/sold 2,009 shares @ $39.1571, valued at $78.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy